SCHEMBL14905936

SCHEMBL14905936

C=CCN(C(=O)OCc1ccccc1)[C@@H](CC[C@@H]1N=C(OC)[C@@H](C(C)C)N=C1OC)C[C@H]1O[C@@H](OC)C2OC(C)(C)OC21

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16156796 1.00 — —
SCHEMBL16156837 0.92 LGALS8 (0.30) —
SCHEMBL14905934 0.84 LGALS8 (0.33) —
SCHEMBL16156791 0.84 LGALS8 (0.33) —
SCHEMBL16193346 0.77 LGALS8 (0.35) —
SCHEMBL14905964 0.77 LGALS8 (0.35) —
SCHEMBL16156839 0.75 ABCB1 (0.36) —
SCHEMBL16193347 0.74 LGALS8 (0.38) —
SCHEMBL16156885 0.72 LTA4H (0.35) —
SCHEMBL14905962 0.72 LTA4H (0.35) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2771343-B1 METHYLTRANSFERASE INHIBITORS FOR TREATING CANCER SLOAN KETTERING INST CANCER (US) 2016-07-13 — — EP disclosed
WO-2013063417-A1 METHYLTRANSFERASE INHIBITORS FOR TREATING CANCER MEMORIAL SLOAN-KETTERING CANCER CENTER (US) 2013-05-02 — — WO disclosed
Send feedback